// App-Quantinova.ai

PO0630 : Lipid Metabolic Profiling of Ex Vivo Isolated Glomeruli as a Screening Platform for Modelling Glomerular Metabolic Dysfunction During Renal Disease

Researchers

Presenter

  • Romoli Simone

Principal Investigators

  • Krause FynnNiclas

  • Griffin JulianL

  • Laerkegaard Hansen PernilleB

  • Woollard Kevin

Medical Centers

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • University of Cambridge Department of Biochemistry Cambridge Cambridgeshire United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Renal disease

Biomarkers

  • Aldo-Keto Reductase Family 1 Member B

Drug/Treatment

  • Adriamycin injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved